Furosemide in patients with heart failure: Shift in dose‐response curves

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Clinical pharmacology and therapy

• Publication date

  1980-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/clpt.1980.148PMID 7398185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deranged sodium homeostasis in cirrhosis.

  1979cited by this paper
• Pharmacodynamic analysis of the furosemide-probenecid interaction in man.

  1979cited by this paper
• Hyponatremic syndromes.

  1978cited by this paper
• Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

  1978cited by this paper
• Effects of probenecid on furosemide response

  1978cited by this paper
• The kidney in heart failure.

  1977cited by this paper
• Sodium retention in dogs with cirrhosis and ascites: efferent mechanisms.

  1977cited by this paper
• Depression of renal clearance of furosemide in man by azotemia

  1977cited by this paper
• A comparison of the diuretic response to oral and intravenous furosemide in "duretic-resistant" patients.

  1977cited by this paper
• Effect of experimental azotemia on renal clearance of furosemide in the dog.

  1976cited by this paper
• Mechanisms of portal hypertension-induced alterations in renal hemodynamics, renal water excretion, and renin secretion.

  1976cited by this paper
• The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.

  1976cited by this paper
• Relationship of urinary furosemide excretion rate to natriuretic effect in experimental azotemia.

  1976cited by this paper
• Mechanism of sodium and water retention in rats with experimental heart failure.

  1973cited by this paper
• Influence of volume expansion on proximal tubular sodium reabsorption in congestive heart failure.

  1973cited by this paper
• Effects of acute volume expansion and altered hemodynamics on renal tubular function in chronic caval dogs.

  1972cited by this paper
• Mechanism of increased renal tubular sodium reabsorption in cirrhosis.

  1972cited by this paper
• Proximal tubular function in dogs with thoracic caval constriction.

  1971cited by this paper
• Sodium reabsorption by proximal tubule of dogs with experimental heart failure.

  1971cited by this paper
• Assessment of proximal tubular sodium reabsorption during water diuresis in patients with heart disease

  1970cited by this paper
• Influence of Sodium Balance on the Ability of Diuretics to Inhibit Tubular Reabsorption: A Study of Factors that Influence Renal Tubular Sodium Reabsorption in Man

  1970cited by this paper
• RENAL EFFECTS OF ACUTE EXPANSION OF PLASMA VOLUME IN CIRRHOSIS.

  1965cited by this paper
• An explanation for and experimental correction of the abnormal water diuresis in cirrhosis.

  1960cited by this paper
• Studies of the serum and urine constituents in patients with cirrhosis of the liver during water tolerance tests.

  1951cited by this paper

• Loop diuretics in anuric hemodialysis patients for the clearance of protein-bound uremic toxins

  2025cites this paper
• Glucocorticoids in Diuretic Resistance: An Emerging Approach for Heart Failure.

  2025cites this paper
• Individual Natriuretic and Diuretic Response in Acute Heart Failure: Insights from the PUSH-AHF Pharmacological Substudy.

  2025cites this paper
• Diuretic Combination Therapy in Acute Heart Failure: An Updated Review.

  2024cites this paper
• Unique Pharmacological Properties and Safety Profiles of Loop Diuretics.

  2024cites this paper
• Methods for the Assessment of Volume Overload and Congestion in Heart Failure

  2024cites this paper
• The blunted loop diuretic response in acute heart failure is driven by reduced tubular responsiveness rather than insufficient tubular delivery. The role of furosemide urine excretion on diuretic and natriuretic response in acute heart failure

  2023cites this paper
• Self-propelled Janus micromotors for pH-responsive release of small molecule drug

  2022cites this paper
• What are the pharmacodynamics of loop diuretics?

  2019cites this paper
• Acute Heart Failure and Pulmonary Edema

  2019cites this paper
• Diuretic Dosing in Heart Failure and Chronic Kidney Disease

  2019cites this paper
• A perspective on diuretic resistance in chronic congestive heart failure

  2017cites this paper
• The complexity of diuretic resistance

  2017cites this paper
• Drug Metabolism in Cardiovascular Disease

  2017cites this paper
• A Ceiling Dose with Furosemide in Systolic Heart Failure: A Myth or a Pertinent Clinical Consideration?

  2016cites this paper
• Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose–Response Curves in Worsening Refractory Congestive Heart Failure

  2015cites this paper
• Intermittent Administration of Furosemide vs Continuous InfusionPrecededbya LoadingDoseforCongestive Heart

  2015cites this paper
• Population‐based meta‐analysis of furosemide pharmacokinetics

  2014cites this paper
• Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.

  2014cites this paper
• Do Any Patients with Acute Decompensated Heart Failure and Acute Cardio‐Renal Syndrome Benefit from Ultrafiltration?

  2014cites this paper
• Effective Use of Loop Diuretics in Heart Failure Exacerbation: A Nephrologist’s View

  2014cites this paper
• Efficacy and safety of loop diuretic therapy in acute decompensated heart failure: a clinical review

  2014cites this paper
• Efficacy and safety of tolvaptan in heart failure patients with volume overload.

  2014cites this paper
• ACCF/AHA Practice Guideline

  2013cites this paper
• The Loop Diuretic Torasemide in Chronic Renal Failure

  2012cites this paper
• Mechanism and management of diuretic resistance in congestive heart failure

  2012cites this paper
• Update in diuretic therapy: clinical pharmacology.

  2011cites this paper
• Diuretics in acute kidney injury.

  2011cites this paper
• Diagnosis and Management of Heart Failure in Adults : 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the

  2011cites this paper
• Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure

  2011cites this paper
• Benefits and risks of furosemide in acute kidney injury

  2010cites this paper
• Drug Benefits and Risks

  2010cites this paper
• FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART

  2009cites this paper
• Thiazides and loop-diuretics therapeutic aspects.

  2009cites this paper
• Foundation/American Heart Association Task Force on Practice Guidelines Heart Failure in Adults. A Report of the American College of Cardiology Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of

  2009cites this paper
• Force on Practice Guidelines, International Society for Heart and Lung American College of Cardiology Foundation/American Heart Association Task Management of Heart Failure in Adults 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and

  2009cites this paper
• ACCF/AHA Practice Guideline: Focused Update Practice Guideline: Focused Update 2009 Focused Update: ACCF/AHA Guidelin s for the Diagnosis and Management of Heart Failure in Adults

  2009cites this paper
• ACCF/AHA Practice Guideline: Focused Update Practice Guideline: Focused Update 2009 Focused Update: ACCF/AHA Guidelin s for the Diagnosis and Management of Heart Failure in Adults

  2009cites this paper
• ACCF/AHA Practice Guideline: Focused Update

  2009cites this paper
• Management of Volume Overload in Acute Heart Failure: Diuretics and Ultrafiltration

  2008cites this paper
• Novel Strategies: Challenge Loop Diuretics and Sodium Management in Heart Failure—Part I

  2007cites this paper
• Novel strategies: challenge loop diuretics and sodium management in heart failure--Part I.

  2007cites this paper
• The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects

  2006cites this paper
• Sequenzielle Nephronblockade: Zusatznutzen von Diuretika‐Kombinationen

  2006cites this paper
• Comparison of the diuretic effect of furosemide mixed with human albumin or fresh frozen plasma for patients with hypoalbuminemia in the intensive care unit.

  2006cites this paper
• Effectiveness of continuous infusions of loop diuretics for severe heart failure

  2006cites this paper
• Diuretics in Pediatrics

  2006cites this paper
• Examination of the constructs of the Transtheoretical model in patients with heart failure: a focus on physical activity readiness

  2006cites this paper
• Vasopressin receptor antagonists in the management of acute heart failure

  2005cites this paper
• Zur Wirkungsweise von Xipamid und seiner Klassifizierung als „Low-ceiling-Diuretikum”

  2005influential citation
• Tratamiento de la insuficiencia cardíaca en fase muy avanzada

  2005cites this paper
• Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy

  2005influential citation
• [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].

  2005cites this paper
• The influence of ascites on the pharmacokinetics of piretanide in cirrhotic patients

  2004cites this paper
• Medikamente zur Therapie kardialer Ödeme

  2004cites this paper
• Renal excretory responses to single and repeated administration of diuretics in healthy subjects: Clinical connotations

  2004cites this paper
• Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.

  2004cites this paper
• Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide

  2004cites this paper
• Development and evaluation of extended-release bumetanide tablets.

  2004cites this paper
• Food: An Unrecognized Source of Loop Diuretic Resistance

  2004cites this paper
• Mechanisms and management of diuretic resistance in congestive heart failure

  2003cites this paper
• A study of the pharmacodynamic differences between immediate and extended release bumetanide formulations.

  2003cites this paper
• Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics.

  2003cites this paper
• Loop diuretics: from the Na-K-2Cl transporter to clinical use.

  2003cites this paper
• Mechanisms and management of diuretic resistance in congestive heart failure.

  2003cites this paper
• Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure.

  2002cites this paper
• Severe Heart Failure in the Elderly

  2002cites this paper
• [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].

  2002cites this paper
• Stellenwert der Aldosteronrezeptorblockade in der diuretischen Therapie von Patienten mit chronischer Herzinsuffizienz

  2002cites this paper
• Neue therapeutische Ansätze zur Behandlung der Diuretikaresistenz unter differenzierter Betrachtung von Bumetanid, Furosemid und Indapamid

  2001cites this paper
• Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.

  2000cites this paper
• Diuretic therapy of heart failure in infants and children.

  2000cites this paper
• Treatment of edematous disorders with diuretics.

  2000cites this paper
• High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema.

  2000cites this paper
• Transport mechanisms for cationic drugs and proteins in kidney, liver and intestine: implication for drug interactions and cell-specific drug delivery.

  1999cites this paper
• Diuretic treatment and diuretic resistance in heart failure.

  1999cites this paper
• Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure.

  1999cites this paper
• Diuretic therapy and diuretic resistance in cardiac failure.

  1999cites this paper
• [Value of diuretics and aldosterone antagonists in the treatment of heart failure].

  1999cites this paper
• Clinical Consequences of the Biphasic Elimination Kinetics for the Diuretic Effect of Furosemide and its Acyl Glucuronide in Humans

  1999cites this paper
• Modulation of drug response by rate of input into the body.

  1998cites this paper
• Combination Diuretic Therapy in Severe Congestive Heart Failure

  1998influential citation
• Diuretika bei Herzinsuffizienz

  1998cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Torasemide

  1998cites this paper
• The clinical pharmacology of loop diuretics in the pediatric patient

  1998cites this paper
• Diuretic therapy.

  1998cites this paper
• [Diuretics in heart failure].

  1998cites this paper
• CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity.

  1998cites this paper
• Pharmacokinetics and pharmacodynamics of triamterene and hydrochlorothiazide and their combination in healthy volunteers.

  1997cites this paper
• Sequential nephron blockade breaks resistance to diuretics in edematous states.

  1997cites this paper
• The benefit of low‐dose dopamine during vigorous diuresis for congestive heart failure associated with renal insufficiency: Does it protect renal function?

  1997cites this paper
• Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.

  1996cites this paper
• Refractory congestive heart failure: overview and application of extracorporeal ultrafiltration.

  1996cites this paper
• Can we improve diuretic response in heart failure?

  1996cites this paper
• Effects of Various Modalities of Oral Furosemide Administration in Mild or Severe Congestive Heart Failure

  1996cites this paper
• Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure

  1995cites this paper
• Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous bumetanide.

  1995cites this paper
• The renin angiotensin aldosterone system and frusemide response in congestive heart failure.

  1995cites this paper
• Clinical Uses of Diuretics

  1995cites this paper
• The use of diuretics in congestive heart failure.

  1994cites this paper